FLX Bio Makes Two Senior Exec Appointments
This article was originally published in Scrip
Executive Summary
FLX Bio Inc., a biopharmaceutical company focused on developing new cancer immunotherapies, has named Dr. Brian Wong CEO and Dr. William Ho chief medical officer.